Literature DB >> 16263718

How dihydrolipoamide dehydrogenase-binding protein binds dihydrolipoamide dehydrogenase in the human pyruvate dehydrogenase complex.

Ewa M Ciszak1, Anna Makal, Young S Hong, Ananthalakshmy K Vettaikkorumakankauv, Lioubov G Korotchkina, Mulchand S Patel.   

Abstract

The dihydrolipoamide dehydrogenase-binding protein (E3BP) and the dihydrolipoamide acetyltransferase (E2) component enzyme form the structural core of the human pyruvate dehydrogenase complex by providing the binding sites for two other component proteins, dihydrolipoamide dehydrogenase (E3) and pyruvate dehydrogenase (E1), as well as pyruvate dehydrogenase kinases and phosphatases. Despite a high similarity between the primary structures of E3BP and E2, the E3-binding domain of human E3BP is highly specific to human E3, whereas the E1-binding domain of human E2 is highly specific to human E1. In this study, we characterized binding of human E3 to the E3-binding domain of E3BP by x-ray crystallography at 2.6-angstroms resolution, and we used this structural information to interpret the specificity for selective binding. Two subunits of E3 form a single recognition site for the E3-binding domain of E3BP through their hydrophobic interface. The hydrophobic residues Pro133, Pro154, and Ile157 in the E3-binding domain of E3BP insert themselves into the surface of both E3 polypeptide chains. Numerous ionic and hydrogen bonds between the residues of three interacting polypeptide chains adjacent to the central hydrophobic patch add to the stability of the subcomplex. The specificity of pairing for human E3BP with E3 is interpreted from its subcomplex structure to be most likely due to conformational rigidity of the binding fragment of the E3-binding domain of E3BP and its exquisite amino acid match with the E3 target interface.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263718     DOI: 10.1074/jbc.M507850200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Successful TAT-mediated enzyme replacement therapy in a mouse model of mitochondrial E3 deficiency.

Authors:  Matan Rapoport; Lina Salman; Ofra Sabag; Mulchand S Patel; Haya Lorberboum-Galski
Journal:  J Mol Med (Berl)       Date:  2010-11-16       Impact factor: 4.599

Review 2.  Data deposition and annotation at the worldwide protein data bank.

Authors:  Shuchismita Dutta; Kyle Burkhardt; Jasmine Young; Ganesh J Swaminathan; Takanori Matsuura; Kim Henrick; Haruki Nakamura; Helen M Berman
Journal:  Mol Biotechnol       Date:  2008-12-10       Impact factor: 2.695

3.  Insight to the interaction of the dihydrolipoamide acetyltransferase (E2) core with the peripheral components in the Escherichia coli pyruvate dehydrogenase complex via multifaceted structural approaches.

Authors:  Krishnamoorthy Chandrasekhar; Junjie Wang; Palaniappa Arjunan; Martin Sax; Yun-Hee Park; Natalia S Nemeria; Sowmini Kumaran; Jaeyoung Song; Frank Jordan; William Furey
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

4.  Novel binding motif and new flexibility revealed by structural analyses of a pyruvate dehydrogenase-dihydrolipoyl acetyltransferase subcomplex from the Escherichia coli pyruvate dehydrogenase multienzyme complex.

Authors:  Palaniappa Arjunan; Junjie Wang; Natalia S Nemeria; Shelley Reynolds; Ian Brown; Krishnamoorthy Chandrasekhar; Guillermo Calero; Frank Jordan; William Furey
Journal:  J Biol Chem       Date:  2014-09-10       Impact factor: 5.157

Review 5.  The pyruvate dehydrogenase complexes: structure-based function and regulation.

Authors:  Mulchand S Patel; Natalia S Nemeria; William Furey; Frank Jordan
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

6.  Characterization of interactions of dihydrolipoamide dehydrogenase with its binding protein in the human pyruvate dehydrogenase complex.

Authors:  Yun-Hee Park; Mulchand S Patel
Journal:  Biochem Biophys Res Commun       Date:  2010-04-10       Impact factor: 3.575

7.  Folding and assembly defects of pyruvate dehydrogenase deficiency-related variants in the E1α subunit of the pyruvate dehydrogenase complex.

Authors:  Srdja Drakulic; Jay Rai; Steen Vang Petersen; Monika M Golas; Bjoern Sander
Journal:  Cell Mol Life Sci       Date:  2018-02-14       Impact factor: 9.261

8.  Solution structure and characterisation of the human pyruvate dehydrogenase complex core assembly.

Authors:  S Vijayakrishnan; S M Kelly; R J C Gilbert; P Callow; D Bhella; T Forsyth; J G Lindsay; O Byron
Journal:  J Mol Biol       Date:  2010-03-31       Impact factor: 5.469

9.  Human 2-oxoglutarate dehydrogenase complex E1 component forms a thiamin-derived radical by aerobic oxidation of the enamine intermediate.

Authors:  Natalia S Nemeria; Attila Ambrus; Hetalben Patel; Gary Gerfen; Vera Adam-Vizi; Laszlo Tretter; Jieyu Zhou; Junjie Wang; Frank Jordan
Journal:  J Biol Chem       Date:  2014-09-10       Impact factor: 5.157

10.  Structural alterations induced by ten disease-causing mutations of human dihydrolipoamide dehydrogenase analyzed by hydrogen/deuterium-exchange mass spectrometry: Implications for the structural basis of E3 deficiency.

Authors:  Attila Ambrus; Junjie Wang; Reka Mizsei; Zsofia Zambo; Beata Torocsik; Frank Jordan; Vera Adam-Vizi
Journal:  Biochim Biophys Acta       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.